Fingerprint

Dive into the research topics of 'Successful administration of sequential TVEC and pembrolizumab followed by temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation'. Together they form a unique fingerprint.

Medicine & Life Sciences